Journal article · 2026 · Open access

Discontinuing Statins in Older Adults without Cardiovascular Disease

Nicolas Rodondi, Moa Lina Haller, Julia B. Bardoczi, Luise Adam, Manuel R. Blum, Bariş Gencer, Tamar Itach, Julian Simon Flury, Lara Aurora Brockhus, Philipp Aebi, Martin Feller, Claudia Gregoriano and 21 more

New England Journal of Medicine · Published 7 November 2026 · DOI 10.1056/nejmoa2606634

Open full textView at the publisherCite this paper

In brief

“Discontinuing Statins in Older Adults without Cardiovascular Disease” is a 2026 journal article by Nicolas Rodondi and 32 co-authors, published in New England Journal of Medicine. OpenAlex counts 0 citations as of 16 November 2026. It is open access: the full text is free to read at Open Access CRIS of the University of Bern.

Citations
0
References
32
Authors
33

Abstract

BACKGROUND: Whether discontinuing statin therapy in older adults with at least two chronic conditions but no known cardiovascular disease affects the time to a first cardiovascular event is not well characterized. METHODS: We conducted an international, open-label, randomized, controlled trial that enrolled adults at least 70 years of age who were taking statins for primary prevention. Participants were randomly assigned in a 1:1 ratio to either discontinue or continue statin therapy and other lipid-lowering therapies. The primary outcome was a composite of nonfatal myocardial infarction, nonfatal ischemic stroke, or death from any cause, whichever occurred first. The primary analysis assessed noninferiority on the basis of the between-group difference in restricted mean event-free survival time at 2 years, with a noninferiority margin of -5.2 weeks. RESULTS: A total of 1880 participants underwent randomization: 938 were assigned to the discontinuation group and 942 to the continuation group. The mean age of the participants was 77.5 years, and 46.9% were women. The between-group difference in the restricted mean event-free survival time at 2 years was -2.0 weeks (95% confidence interval, -3.7 to -0.3; P<0.001 for noninferiority). Over a median follow-up of 103 weeks, 119 participants (12.7%) in the discontinuation group and 87 (9.2%) in the continuation group had a primary-outcome event. At least one serious adverse event occurred in 43.0% of the participants in the discontinuation group and in 39.8% in the continuation group. CONCLUSIONS: Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuation of statin therapy was noninferior to continuation with respect to major cardiovascular events or death from any cause at 2 years. (Funded by the Swiss National Science Foundation; STREAM ClinicalTrials.gov number, NCT05178420.).

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rodondi, N., Haller, M. L., Bardoczi, J. B., Adam, L., Blum, M. R., Gencer, B., Itach, T., Flury, J. S., Brockhus, L. A., Aebi, P., Feller, M., Gregoriano, C., de La Harpe, R., Gussekloo, J., Schwab, N., Poulizac, P., Mooijaart, S. P., Beer, J. H., Baggio, S., . . . Trelle, S. (2026). Discontinuing Statins in Older Adults without Cardiovascular Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2606634

MLA 9

Rodondi, Nicolas, et al. “Discontinuing Statins in Older Adults without Cardiovascular Disease.” New England Journal of Medicine, 2026. https://doi.org/10.1056/nejmoa2606634.

Chicago

Rodondi, Nicolas, Moa Lina Haller, Julia B. Bardoczi, Luise Adam, Manuel R. Blum, Bariş Gencer, Tamar Itach, et al. 2026. “Discontinuing Statins in Older Adults without Cardiovascular Disease.” New England Journal of Medicine. https://doi.org/10.1056/nejmoa2606634.

Harvard

Rodondi, N. et al. (2026) ‘Discontinuing Statins in Older Adults without Cardiovascular Disease’, New England Journal of Medicine. doi:10.1056/nejmoa2606634.

IEEE

N. Rodondi et al., “Discontinuing Statins in Older Adults without Cardiovascular Disease,” New England Journal of Medicine, 2026, doi: 10.1056/nejmoa2606634.

BibTeX

@article{rodondi2026discontinuing,
  title     = {{Discontinuing Statins in Older Adults without Cardiovascular Disease}},
  author    = {Rodondi, Nicolas and Haller, Moa Lina and Bardoczi, Julia B. and Adam, Luise and Blum, Manuel R. and Gencer, Bariş and Itach, Tamar and Flury, Julian Simon and Brockhus, Lara Aurora and Aebi, Philipp and Feller, Martin and Gregoriano, Claudia and de La Harpe, Roxane and Gussekloo, Jacobijn and Schwab, Nathalie and Poulizac, Pierre and Mooijaart, Simon Pieter and Beer, Jürg Hans and Baggio, Stéphanie and Carballo, Sebastian and Bonnet, Fabrice and Zekry, Dina and Gabutti, Luca and Wertli, Maria Monika and Aujesky, Drahomir and Bauer, Douglas Charles and Redberg, Rita F. and Greenland, Philip and Poortvliet, Rosalinde K. E. and Schüetz, Philipp and others},
  journal   = {New England Journal of Medicine},
  year      = {2026},
  doi       = {10.1056/nejmoa2606634},
  url       = {https://doi.org/10.1056/nejmoa2606634}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health

  • statin discontinuation
  • statin therapy
  • older adults
  • primary prevention
  • cardiovascular events
  • myocardial infarction
  • ischemic stroke
  • mortality

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Rodondi, N., Haller, M. L., Bardoczi, J. B., Adam, L., Blum, M. R., Gencer, B., Itach, T., Flury, J. S., Brockhus, L. A., Aebi, P., Feller, M., Gregoriano, C., de La Harpe, R., Gussekloo, J., Schwab, N., Poulizac, P., Mooijaart, S. P., Beer, J. H., Baggio, S., . . . Trelle, S. (2026). Discontinuing Statins in Older Adults without Cardiovascular Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2606634

How many times has this paper been cited?

0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Open Access CRIS of the University of Bern: sign in and open the full text from this page.

Who wrote this paper?

Nicolas Rodondi, Moa Lina Haller, Julia B. Bardoczi, Luise Adam, Manuel R. Blum, Bariş Gencer, Tamar Itach, Julian Simon Flury, Lara Aurora Brockhus, Philipp Aebi, Martin Feller, Claudia Gregoriano and 21 more.

What is the DOI of this paper?

10.1056/nejmoa2606634, permanently at https://doi.org/10.1056/nejmoa2606634. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.